[-] Show simple item record

dc.contributor.authorHaynes, Jamieeng
dc.contributor.authorKelsberg, Garyeng
dc.contributor.authorJamieson, Barbaraeng
dc.date.issued2008eng
dc.description.abstractPatients with moderate to high cardiac risk (a Revised Cardiac Risk Index [RCRI] score of 2 or higher [Table]) have a reduced risk of in-hospital death following perioperative beta-blocker therapy (strength of recommendation [SOR]: B, based on a large retrospective cohort study). There is, however, no proven benefit to perioperative beta-blocker therapy without prior cardiac risk stratification (SOR: A, based on systematic reviews).eng
dc.identifier.urihttp://hdl.handle.net/10355/3844eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2008 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 57, no. 02 (February 2008): 121-123.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcardiovascular riskeng
dc.subjectmyocardial ischemiaeng
dc.subjectvascular surgeryeng
dc.subject.lcshAdrenergic beta blockerseng
dc.subject.lcshHeart -- Diseases -- Complicationseng
dc.subject.lcshSurgery -- Complications -- Preventioneng
dc.titleWhich patients undergoing noncardiac surgery benefit from perioperative beta-blockers?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record